Medicare CGM Access Act of 2015

H.R.1427 - Medicare CGM Access Act of 2015 - 114th Congress (2015-2016), Administrative law and regulatory procedures / Department of Health and Human Services / Digestive and metabolic diseases / Health technology, devices, supplies / Medicare. This bill amends title XVIII (Medicare) of the Social Security Act to provide Medicare coverage of continuous glucose monitoring (CGM) devices furnished to a CGM qualified individual. The Department of Health and Human Services must establish a fee schedule and ensure that CGM qualified individuals are furnished with appropriate device components.

Client expense: Not reported · Firm income: $25,650

Government targets: HOUSE OF REPRESENTATIVES

H.R. 1427/S. 804 - Medicare CGM Access Act of 2015 H.R. 6 - 21st Century Cures Act S. 2700 - FDA and NIH Workforce Authorities Modernization Act H.R. 1192/S. 586 - National Diabetes Clinical Care Commission Act

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

no specific bill - medicare coverage and reimbursement, continuous glucose monitors, chronic care PL 111-148 - The Patient Protection and Affordable Care Act, implementation issues related to diabetes care H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 1470/S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 H.R. 1427/S. 804 - Medicare CGM Access Act of 2015

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.

Client expense: $540,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to competitive bidding for DME products. H.R. 5210 and S. 2736- Patient Access to Durable Medical Equipment Act- provisions related to patient access. H.R. 1427/S.804- Medicare CGM Access Act of 2015- Provisions related to continuous glucose monitoring.

Client expense: $40,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1427 & S.804-Medicare CGM Access Act of 2015

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3762, Restoring Americans Healthcare Freedom Reconciliation Act H.R. 592/S. 314, Pharmacy and Medically Underserved Areas Enhancement Act H.R. 954, CO-OP Consumer Protection Act of 2016 H.R. 1190/S. 141, The Protecting Seniors Access to Medicare Act of 2015 H.R. 1192, National Clinical Care Commission Act H.R. 1270, Restoring Access to Medication and Improving Health Savings Act H.R. 1427, Medicare CGM Access Act H.R. 1686/S. 3082, Preventing Diabetes in Medicare Act H.R. 1707, Access to Frontline Health Care Act of 2015 H.R. 1726, Access to Quality Diabetes Education Act H.R. 1807, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 H.R. 2102, Medicare Diabetes Prevention Act H.R. 2124/S. 1148, Resident Physician Shortage Act H.R. 2603/S. 1475, Saving Lives, Saving Costs Act H.R. 2646, Helping Families in Mental Crisis Act H.R. 2713/S. 3245, Title VIII Nursing Workforce Reauthorization Act of 2016 H.R. 3081/S. 1778, Telemedicine for Medicare Act H.R. 3119/S. 2748, Palliative Care and Hospice Education and Training Act H.R. 3660/S. 3126,Preventive Health Savings Act H.R. 3952/S. 2248, Congenital Heart Future Reauthorization Act of 2015 H.R. 4212/S. 704, Community Based Independence for Seniors Act of 2015 H.R. 4442/S. 2484, CONNECT for Health Act H.R. 4732/S. 2671, Advancing Medical Resident Training in Community Hospitals Act H.R. 4774, Training Tomorrows Doctors Today Act H.R. 4909/S. 2943, National Defense Authorization Act H.R. 5273, Helping Hospitals Improve Patient Care Act H.R. 5414, FDA Cross-Center Collaboration Act H.R. 5447/S. 3060, The Small Business Health Care Relief Act H.R. 5652,Access to Better Care Act H.R. 5681/S. 3137, Alzheimers Beneficiary and Caregiver Support Act H.R. 5713, Sustaining Healthcare Integrity and Fair Treatment Act of 2016 H.R.5926 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017 H.R. 6043/S. 3335, The Fair Accountability and Innovative Research Drug Pricing Act of 2016 H.R. 6109/S. 3371, Medicare Affordability and Enrollment Act S. 524, Comprehensive Addiction and Recovery Act S. 586, National Diabetes Clinical Care Commission Act S. 603, Jobs and Premium Protection Act S. 776,Medication Therapy Management Empowerment Act S. 1077,Advancing Breakthrough Medical Devices for Patients Act S. 1101,Medical Electronic Data Technology Enhancement for Consumers Health (MEDTECH) Act S. 1622,FDA Device Accountability Act S. 2511,Improving Health Information Technology Act S. 2680,Mental Health Reform Act of 2016 S. 2864,Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2016 S. 3326,State Flexibility to Provide Affordable Health Options Act S. 3504, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2016 Pub. L. 111-5, The American Recovery and Reinvestment Act of 2009 (Health Information Technology for Economic and Clinical Health Act (HITECH) Pub. L. 111-148, Patient Protection and Affordable Care Act (PPACA) Pub. L. 114-10, Medicare Access and CHIP Reauthorization Act (MACRA) Pub. L. 114-255,21st Century Cures Pub. L. 114-270, Expanding Capacity for Health Outcomes Act (ECHO) Pub. L. 114-328, National Defense Authorization Act for Fiscal Year 2017

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1190/S. 141, The Protecting Seniors Access to Medicare Act of 2015 H.R. 1270, Restoring Access to Medication and Improving Health Savings Act H.R. 1427, Medicare CGM Access Act H.R. 1686/S. 3082, Preventing Diabetes in Medicare Act H.R. 1707, Access to Frontline Health Care Act of 2015 H.R. 1726, Access to Quality Diabetes Education Act H.R. 2102, Medicare Diabetes Prevention Act H.R. 2124/S. 1148, Resident Physician Shortage Act H.R. 2603/S. 1475, Saving Lives, Saving Costs Act H.R. 3119/S. 2748, Palliative Care and Hospice Education and Training Act H.R. 3660/S. 3126,Preventive Health Savings Act H.R. 3952/S. 2248, Congenital Heart Future Reauthorization Act of 2015 H.R. 4212/S. 704, Community Based Independence for Seniors Act of 2015 H.R. 5273, Helping Hospitals Improve Patient Care Act H.R. 5681/S. 3137, Alzheimers Beneficiary and Caregiver Support Act H.R.5926 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017 H.R. 6043/S. 3335, The Fair Accountability and Innovative Research Drug Pricing Act of 2016 H.R. 6109/S. 3371, Medicare Affordability and Enrollment Act S. 776,Medication Therapy Management Empowerment Act S. 1077,Advancing Breakthrough Medical Devices for Patients Act S. 1101,Medical Electronic Data Technology Enhancement for Consumers Health (MEDTECH) Act S. 2864,Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2016 S. 3326,State Flexibility to Provide Affordable Health Options Act Pub. L. 111-5, The American Recovery and Reinvestment Act of 2009 (Health Information Technology for Economic and Clinical Health Act (HITECH) Pub. L. 114-10, Medicare Access and CHIP Reauthorization Act (MACRA) Pub. L. 114-255,21st Century Cures

Client expense: $150,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Medicare Reimbursement issues for physician services and diabetes care; meaningful use; chronic care reform proposals; Evaluation & Management code reform. HR 1427/ S 804, Medicare CGM Access Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

S.804/HR.1427 MEDICARE CGM ACCESS ACT OF 2015, S.586/HR1192 NDCCA, S.1345/HR 1726 ACCESS TO QUALITY DIABETES EDUCATION ACT, S.1131/HR2102 MEDICARE NDPP, HR 771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, MEDICARE COMPETITIVE BIDDING PROGRAM,

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 1427 & S 804 - Medicare CGM Access Act of 2015

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1427 - Medicare CGM Access Act of 2015 - 114th Congress (2015-2016), Administrative law and regulatory procedures / Department of Health and Human Services / Digestive and metabolic diseases / Health technology, devices, supplies / Medicare. This bill amends title XVIII (Medicare) of the Social Security Act to provide Medicare coverage of continuous glucose monitoring (CGM) devices furnished to a CGM qualified individual. The Department of Health and Human Services must establish a fee schedule and ensure that CGM qualified individuals are furnished with appropriate device components.

Client expense: Not reported · Firm income: $12,750

Government targets: HOUSE OF REPRESENTATIVES

Issues related to competitive bidding for DME products. H.R. 5210 and S. 2736- Patient Access to Durable Medical Equipment Act- provisions related to patient access. H.R. 1427/S.804- Medicare CGM Access Act of 2015- Provisions related to continuous glucose monitoring.

Client expense: $40,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.

Client expense: $940,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1427 and S.804, Medicare CGM Access Act of 2015; issues related to physician-owned distributorship; issues related to competitive bidding of DME; monitored issues related to Unique Device Identifier and Medicare claims.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1427/S. 804 - Medicare CGM Access Act of 2015 H.R. 6 - 21st Century Cures Act S. 2700 - FDA and NIH Workforce Authorities Modernization Act H.R. 1192/S. 586 - National Diabetes Clinical Care Commission Act

Client expense: $170,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive. - Issues related to Expanded Access. - S. 2736/ HR 5210, "Patient Access to Durable Medical Equipment Act of 2016", regarding all provisions. - Issues related to competitive bidding for DME products. - S. 2484, "Connect for Health Act", Provisions related to expanded use of RPM for certain patients with chronic conditions.

Client expense: $890,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R. 1427 & S.804-Medicare CGM Access Act of 2015

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

no specific bill - medicare coverage and reimbursement, continuous glucose monitors, chronic care PL 111-148 - The Patient Protection and Affordable Care Act, implementation issues related to diabetes care H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 1470/S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 H.R. 1427/S. 804 - Medicare CGM Access Act of 2015

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 804/H.R. 1427, the Medicare CGM Access Act. Support entire bill; provides Medicare coverage for continuous glucose monitoring (CGM) devices to qualified individuals.

Client expense: $108,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Medicare Reimbursement issues for physician services and diabetes care; meaningful use; chronic care reform proposals; Evaluation & Management code reform. HR 1427/ S 804, Medicare CGM Access Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1190/S. 141, The Protecting Seniors Access to Medicare Act of 2015 H.R. 1192, National Diabetes Clinical Care Commission Act H.R. 1270, Restoring Access to Medication and Improving Health Savings Act H.R. 1427, Medicare CGM Access Act H.R. 1686/S. 3082, Preventing Diabetes in Medicare Act H.R. 2102, Medicare Diabetes Prevention Act H.R. 5652,Access to Better Care Act S. 3326, State Flexibility to Provide Affordable Health Options Act

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 6 ,21st Century Cares H.R. 592/S. 314, Pharmacy and Medically Underserved Areas Enhancement Act H.R. 1190/S. 141, The Protecting Seniors Access to Medicare Act of 2015 H.R. 1192, National Diabetes Clinical Care Commission Act H.R. 1270, Restoring Access to Medication and Improving Health Savings Act H.R. 1427, Medicare CGM Access Act H.R. 1686/S. 3082, Preventing Diabetes in Medicare Act H.R. 1726, Access to Quality Diabetes Education Act H.R. 2102, Medicare Diabetes Prevention Act H.R. 2124/S. 1148, Resident Physician Shortage Act H.R. 2603/S. 1475, Saving Lives, Saving Costs Act H.R. 2646, Helping Families in Mental Crisis Act H.R. 3081/S. 1778, Telemedicine for Medicare Act H.R. 3660/S. 3126,Preventive Health Savings Act H.R. 4212/S. 704, Community Based Independence for Seniors Act of 2015 H.R. 4442/S. 2484, CONNECT for Health Act H.R. 4732/S. 2671, Advancing Medical Resident Training in Community Hospitals Act H.R. 4774, Training Tomorrows Doctors Today Act H.R. 4909/S. 2943, National Defense Authorization Act H.R. 5273, Helping Hospitals Improve Patient Care Act H.R. 5395, Expanding Capacity for Health Outcomes Act H.R. 5414, FDA Cross-Center Collaboration Act H.R. 5447/S. 3060, The Small Business Health Care Relief Act H.R. 5652,Access to Better Care Act H.R. 5681/S. 3137, Alzheimers Beneficiary and Caregiver Support Act H.R. 6043/S. 3335, The Fair Accountability and Innovative Research Drug Pricing Act of 2016 S. 524, Comprehensive Addiction and Recovery Act S. 754, Cybersecurity Information Sharing Act (CISA) S. 776,Medication Therapy Management Empowerment Act S. 1077,Advancing Breakthrough Medical Devices for Patients Act S. 1101,Medical Electronic Data Technology Enhancement for Consumers Health (MEDTECH) Act S. 1622,FDA Device Accountability Act S. 2511,Improving Health Information Technology Act S. 2680,Mental Health Reform Act of 2016 S. 2864,Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2016 S. 3326, State Flexibility to Provide Affordable Health Options Act

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

- HR3204 Drug Quality & Security Act regarding 3PL licensing & serialization standards and federal licensing of 3PLs; support for Federal license for 3PL and wholesale distribution of medical devices in the U.S. - HR 1427/S804 Medicare CGM Access Act of 2015 to have Constant Glucose Monitoring Devices for diabetes therapies covered by private insurance to be covered by Medicare. - "Special Diabetes Program Funding" - assist healthcare clients & JDRF gain signatures for Senate support of $150M special program funding.

Client expense: $1,354,916 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Pension Benefit Guaranty Corporation (PBGC), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

- HR3204 Drug Quality & Security Act regarding 3PL licensing & serialization standards and federal licensing of 3PLs; support for Federal license for 3PL and wholesale distribution of medical devices in the U.S. - HR 1427/S804 Medicare CGM Access Act of 2015 to have Constant Glucose Monitoring Devices for diabetes therapies covered by private insurance to be covered by Medicare. - "Special Diabetes Program Funding" - assist healthcare clients & JDRF gain signatures for Senate support of $150M special program funding.

Client expense: $1,354,916 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Pension Benefit Guaranty Corporation (PBGC), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

S.804/HR.1427 MEDICARE CGM ACCESS ACT OF 2015, S.586/HR1192 NDCCA, S.1345/HR 1726 ACCESS TO QUALITY DIABETES EDUCATION ACT, S.1131/HR2102 MEDICARE NDPP, HR 771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, MEDICARE COMPETITIVE BIDDING PROGRAM, Docket No. FDA-2016-N-0400 FDA LANCET DEVICES GUIDANCE DOCKET, Docket No. FDA-2016-N-0001 FDA DIABETES DEXCOM G5 LABELING CHANGE

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 1427 & S 804 - Medicare CGM Access Act of 2015

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1427/S. 804 Medicare CGM Access Act H.R. 3081/ S. 1778 TELEmedicine for MEDicare (TELE-MED) Act H.R. 1190/S. 141 Protecting Seniors' Access to Medicare Act H.R. 2446 To amend title XIX of the Social Security Act to require the use of electronic visit verification for personal care services furnished under the Medicaid program, and for other purposes. H.R. 3821 Medicaid Directory of Caregivers Act S.2104 Preserving Medicare Advantage for all Medicare Beneficiaries Act

Client expense: $160,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

- HR 1427/S 804, "Medicare CGM Access Act of 2015", regarding all provisions. - HR 284, "Medicare DMEPOS Competitive Bidding Improvement Act of 2015", regarding all provisions. - Issues regarding combination products. - Issues regarding Transferable Regulatory Exclusivity Incentive. - Issues related to Expanded Access. - S. 2736, "Patient Access to Durable Medical Equipment Act of 2016", regarding all provisions.

Client expense: $2,040,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R. 1427/S.804 - Medicare CGM Access Act of 2015 - provisions related to continuous glucose monitoring. Issues related to competitive bidding for DME products. Issues related to physician-owned distributors. H.R. 5210/S. 2736 - Patient Access to Durable Medical Equipment Act - provisions related to patient access.

Client expense: $920,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

no specific bill - medicare coverage and reimbursement, continuous glucose monitors, chronic care PL 111-148 - The Patient Protection and Affordable Care Act, implementation issues related to diabetes care H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015 H.R. 1470/S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015 H.R. 1427/S. 804 - Medicare CGM Access Act of 2015

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 1427 & S 804 - Medicare CGM Access Act of 2015

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobbied for support of H.R. 1427 and having met with Rep. David McKinley - WV, Rep. Darrell Issa - CA, Rep. Bill Huizenga - MI, Rep. Bill Johnson - OH, Rep. Candace Miller - MI, Rep. Robert Pittenger - NC, Rep. Jim Cooper - TN, Rep. Rick Crawford - AR, Rep. Kay Granger-TX, Rep. Sam Graves - GA, Rep. Ed Whitfield - KY, Rep. Culberson - TX, Rep. Jeb Hensarling - TX, and Rep. Kevin Cramer -ND.

Client expense: Not reported · Firm income: $36,000

Government targets: HOUSE OF REPRESENTATIVES

- HR3204 Drug Quality & Security Act regarding 3PL licensing & serialization standards and federal licensing of 3PLs; support for Federal license for 3PL and wholesale distribution of medical devices in the U.S. - HR 1427/S804 Medicare CGM Access Act of 2015 to have Constant Glucose Monitoring Devices for diabetes therapies covered by private insurance to be covered by Medicare.

Client expense: $1,680,927 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Postal Regulatory Commission, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Customs & Border Protection, U.S. Postal Service (USPS), U.S. Trade Representative (USTR), White House Office

S. 1131/H.R. 2102, the Medicare Diabetes Prevention Act. Support entire bill; provides Medicare coverage for the National Diabetes Prevention Program to individuals with prediabetes. Also support regulatory pathway to achieve Medicare coverage of National DPP announced in March. S. 804/H.R. 1427, the Medicare CGM Access Act. Support entire bill; provides Medicare coverage for continuous glucose monitoring (CGM) devices to qualified individuals. H.R. 1686, the Preventing Diabetes in Medicare Act of 2015. Support entire bill; extends Medicare coverage of medical nutrition therapy services to people with prediabetes and other risk factors for developing type 2 diabetes.

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1427/S. 804 - Medicare CGM Access Act of 2015 H.R. 6 - 21st Century Cures Act S. 2700 - FDA and NIH Workforce Authorities Modernization Act S. 2689/H.R. 4762 - Reliable and Effective Growth for Regenerative Health Options that Improve Wellness Act

Client expense: $190,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1427 & S 804 - Medicare CGM Access Act of 2015; HR 5210 - Patient Access to Durable Medical Equipment Act of 2016

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1427 and S.804, Medicare CGM Access Act of 2015; issues related to physician-owned distributorship; issues related to competitive bidding of DME; issues related to Unique Device Identifier and Medicare claims.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Research in Endocrinology; HR 6 House 21st Century Cures bill; Senate Innovations for Healthier Americans bill, S. 2745; HR 2101 Research for All act of 2015; inclusion in research; S. 1101 MEDTECH Act, HR 1427/ S 804, Medicare CGM Access Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

S.804/HR.1427 MEDICARE CGM ACCESS ACT OF 2015, S.586/HR1192 NDCCA, S.1345/HR 1726 ACCESS TO QUALITY DIABETES EDUCATION ACT, S.1131/HR2102 MEDICARE NDPP, HR 771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, MEDICARE COMPETITIVE BIDDING PROGRAM, Docket No. FDA-2016-N-0400 FDA LANCET DEVICES GUIDANCE DOCKET, Docket No. FDA-2016-N-0001 FDA DIABETES DEXCOM G5 LABELING CHANGE

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.804/HR.1427 - MEDICARE CGM ACCESS ACT OF 2015, S.586/HR.1192 - NDCCA, S.1345/HR 1726 ACCESS TO DIABETES QUALITY EDUCATION ACT, S.1131/HR.2102 MEDICARE NDPP, HR.771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, SPECIAL DIABETES FUNDING PROGRAM, CMS COMPETITIVE BIDDING PROGRAMS FOR DIABETES SUPPLIES, RESTRICTION OF ACCESS TO DIABETES TREATMENTS BY INSURANCE PROVIDERS

Client expense: Not reported · Firm income: Not reported

S.804/HR.1427 - MEDICARE CGM ACCESS ACT OF 2015, S.586/HR.1192 - NDCCA, S.1345/HR 1726 ACCESS TO DIABETES QUALITY EDUCATION ACT, S.1131/HR.2102 MEDICARE NDPP, HR.771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, SPECIAL DIABETES FUNDING PROGRAM, CMS COMPETITIVE BIDDING PROGRAMS FOR DIABETES SUPPLIES, RESTRICTION OF ACCESS TO DIABETES TREATMENTS BY INSURANCE PROVIDERS

Client expense: Not reported · Firm income: Not reported

S.804/HR.1427 - MEDICARE CGM ACCESS ACT OF 2015, S.586/HR.1192 - NDCCA, S.1345/HR 1726 ACCESS TO DIABETES QUALITY EDUCATION ACT, S.1131/HR.2102 MEDICARE NDPP, HR.771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, SPECIAL DIABETES FUNDING PROGRAM, CMS COMPETITIVE BIDDING PROGRAMS FOR DIABETES SUPPLIES, RESTRICTION OF ACCESS TO DIABETES TREATMENTS BY INSURANCE PROVIDERS

Client expense: Not reported · Firm income: Not reported

S.804/HR.1427 - MEDICARE CGM ACCESS ACT OF 2015, S.586/HR.1192 - NDCCA, S.1345/HR 1726 ACCESS TO DIABETES QUALITY EDUCATION ACT, S.1131/HR.2102 MEDICARE NDPP, HR.771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, SPECIAL DIABETES FUNDING PROGRAM, CMS COMPETITIVE BIDDING PROGRAMS FOR DIABETES SUPPLIES, RESTRICTION OF ACCESS TO DIABETES TREATMENTS BY INSURANCE PROVIDERS

Client expense: Not reported · Firm income: Not reported

S.804/HR.1427 - MEDICARE CGM ACCESS ACT OF 2015, S.586/HR.1192 - NDCCA, S.1345/HR 1726 ACCESS TO DIABETES QUALITY EDUCATION ACT, S.1131/HR.2102 MEDICARE NDPP, HR.771 PROTECTING ACCESS TO DIABETES SUPPLIES ACT, HR 1686 MEDICARE PREVENTION NUTRITION EDUCATION, SPECIAL DIABETES FUNDING PROGRAM, CMS COMPETITIVE BIDDING PROGRAMS FOR DIABETES SUPPLIES, RESTRICTION OF ACCESS TO DIABETES TREATMENTS BY INSURANCE PROVIDERS

Client expense: Not reported · Firm income: Not reported